DCT develops tests that detect presymptomatic cognitive impairment and aid in tracking cognitive change. In under 2 minutes, DCT can identify subtle cognitive features that may be indicative of impairment, even in people who appear to be functioning normally.
All of DCT’s tests are designed to be easy to administer and non-invasive. The tests use patented technology to capture and analyze micro-movements of drawing behavior, which reflect memory and thinking processes. DCT’s proprietary analysis instantly delivers accurate and objective indicators of cognitive state, all for a fraction of the price of imaging and biomarker analysis.
